ROVI — Laboratorios Farmaceuticos Rovi SA Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Market Cap
€4.04bn
Enterprise Value
€4.07bn
Revenue
€743.48m

Annual balance sheet for Laboratorios Farmaceuticos Rovi SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	99	125	25.3	27.4	98
Net Total Accounts Receivable
Net Total Receivables	160	184	143	130	178
Total Inventory
Prepaid Expenses
Total Current Assets	506	623	509	490	567
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	182	216	254	287	331
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	733	879	800	832	956
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	190	294	200	157	181
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	262	359	260	260	291
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	471	520	539	572	664
Total Liabilities & Shareholders' Equity	733	879	800	832	956
Total Common Shares Outstanding